BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24408909)

  • 1. A Saccharomyces cerevisiae model reveals in vivo functional impairment of the Ogden syndrome N-terminal acetyltransferase NAA10 Ser37Pro mutant.
    Van Damme P; Støve SI; Glomnes N; Gevaert K; Arnesen T
    Mol Cell Proteomics; 2014 Aug; 13(8):2031-41. PubMed ID: 24408909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein N-terminal acetyltransferases act as N-terminal propionyltransferases in vitro and in vivo.
    Foyn H; Van Damme P; Støve SI; Glomnes N; Evjenth R; Gevaert K; Arnesen T
    Mol Cell Proteomics; 2013 Jan; 12(1):42-54. PubMed ID: 23043182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal acetylome analysis reveals the specificity of Naa50 (Nat5) and suggests a kinetic competition between N-terminal acetyltransferases and methionine aminopeptidases.
    Van Damme P; Hole K; Gevaert K; Arnesen T
    Proteomics; 2015 Jul; 15(14):2436-46. PubMed ID: 25886145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the functionality of a ribosome-binding mutant of NAA15 using Saccharomyces cerevisiae.
    Varland S; Arnesen T
    BMC Res Notes; 2018 Jun; 11(1):404. PubMed ID: 29929531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans.
    Arnesen T; Van Damme P; Polevoda B; Helsens K; Evjenth R; Colaert N; Varhaug JE; Vandekerckhove J; Lillehaug JR; Sherman F; Gevaert K
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8157-62. PubMed ID: 19420222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and cellular analysis of Ogden syndrome reveals downstream Nt-acetylation defects.
    Myklebust LM; Van Damme P; Støve SI; Dörfel MJ; Abboud A; Kalvik TV; Grauffel C; Jonckheere V; Wu Y; Swensen J; Kaasa H; Liszczak G; Marmorstein R; Reuter N; Lyon GJ; Gevaert K; Arnesen T
    Hum Mol Genet; 2015 Apr; 24(7):1956-76. PubMed ID: 25489052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of N-terminal acetyltransferase A activity induces thermally unstable ribosomal proteins and increases their turnover in Saccharomyces cerevisiae.
    Guzman UH; Aksnes H; Ree R; Krogh N; Jakobsson ME; Jensen LJ; Arnesen T; Olsen JV
    Nat Commun; 2023 Jul; 14(1):4517. PubMed ID: 37500638
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    McTiernan N; Darbakk C; Ree R; Arnesen T
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and Mechanism of Acetylation by the N-Terminal Dual Enzyme NatA/Naa50 Complex.
    Deng S; Magin RS; Wei X; Pan B; Petersson EJ; Marmorstein R
    Structure; 2019 Jul; 27(7):1057-1070.e4. PubMed ID: 31155310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
    Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
    Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded in vivo substrate profile of the yeast N-terminal acetyltransferase NatC.
    Van Damme P; Osberg C; Jonckheere V; Glomnes N; Gevaert K; Arnesen T; Aksnes H
    J Biol Chem; 2023 Feb; 299(2):102824. PubMed ID: 36567016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic and genomic characterization of a yeast model for Ogden syndrome.
    Dörfel MJ; Fang H; Crain J; Klingener M; Weiser J; Lyon GJ
    Yeast; 2017 Jan; 34(1):19-37. PubMed ID: 27668839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel NAA10 p.(R83H) variant with impaired acetyltransferase activity identified in two boys with ID and microcephaly.
    Ree R; Geithus AS; Tørring PM; Sørensen KP; Damkjær M; ; Lynch SA; Arnesen T
    BMC Med Genet; 2019 Jun; 20(1):101. PubMed ID: 31174490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of Human NatA and Its Regulation by the Huntingtin Interacting Protein HYPK.
    Gottlieb L; Marmorstein R
    Structure; 2018 Jul; 26(7):925-935.e8. PubMed ID: 29754825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications for the evolution of eukaryotic amino-terminal acetyltransferase (NAT) enzymes from the structure of an archaeal ortholog.
    Liszczak G; Marmorstein R
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14652-7. PubMed ID: 23959863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment.
    Casey JP; Støve SI; McGorrian C; Galvin J; Blenski M; Dunne A; Ennis S; Brett F; King MD; Arnesen T; Lynch SA
    Sci Rep; 2015 Nov; 5():16022. PubMed ID: 26522270
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kweon HY; Lee MN; Dorfel M; Seo S; Gottlieb L; PaPazyan T; McTiernan N; Ree R; Bolton D; Garcia A; Flory M; Crain J; Sebold A; Lyons S; Ismail A; Marchi E; Sonn SK; Jeong SJ; Jeon S; Ju S; Conway SJ; Kim T; Kim HS; Lee C; Roh TY; Arnesen T; Marmorstein R; Oh GT; Lyon GJ
    Elife; 2021 Aug; 10():. PubMed ID: 34355692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charting the N-Terminal Acetylome: A Comprehensive Map of Human NatA Substrates.
    Van Damme P
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel human NatA Nalpha-terminal acetyltransferase complex: hNaa16p-hNaa10p (hNat2-hArd1).
    Arnesen T; Gromyko D; Kagabo D; Betts MJ; Starheim KK; Varhaug JE; Anderson D; Lillehaug JR
    BMC Biochem; 2009 May; 10():15. PubMed ID: 19480662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAA10 dysfunction with normal NatA-complex activity in a girl with non-syndromic ID and a de novo NAA10 p.(V111G) variant - a case report.
    McTiernan N; Støve SI; Aukrust I; Mårli MT; Myklebust LM; Houge G; Arnesen T
    BMC Med Genet; 2018 Mar; 19(1):47. PubMed ID: 29558889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.